UofL Health – UofL Hospital

What it reported doing in 2024

University medical center operates the university of louisville hospital and brown cancer center. Uofl health - uofl hospital, an academic teaching and research hospital with 404 licensed beds, is at the heart of the louisville metro area in downtown louisville. Uofl hospital offers a second-to-none cancer center, world-renowned trauma team and a uniquely streamlined, nationally accredited stroke center - the latest innovations in a history of world-class care. Uofl hospital is the only adult level i trauma center in the region. The trauma center admits more than 3,000 patients each year, including 1,500 patients a year who live outside jefferson county and its surrounding counties, making it a resource not only for louisville residents but also for people throughout kentuckiana. Included within the trauma care provided at uofl hospital is the only dedicated burn center in Kentucky. Within uofl hospital, uofl health brown cancer center features multidisciplinary teams specializing in treating cancers of the blood and bone marrow, breast, head and neck, lungs, and skin, as well as the central nervous system (brain and spine), gastrointestinal, genitourinary and reproductive systems. Key service lines include: 24/7 emergency care and level i trauma center, academic medical center, brown cancer center, burn center, comprehensive stroke center, high-risk obstetrics services, robotic surgical care, including ear, nose and throat, gynecologic and surgical oncology, urology and urogynecology, general and colorectal surgery. Uofl health brown cancer center is an academic cancer center affiliated with the uofl school of medicine. The cancer center's goal is to make cancer a disease of the past through cutting-edge care, innovative clinical trials and cancer prevention efforts. Brown cancer center is home to Kentucky's first and longest-accredited program by the national accreditation program for breast centers. We are a nationally recognized center for developing experimental cancer therapeutics and diagnostics and have the most significant cancer trials program in the region. We are a global leader in the clinical trial testing of new immunotherapies that activate your body's immune system to fight cancer and have become early adopters of these immunotherapies that reduce the cancer death rate in the u.s. The center for cancer immunology and immunotherapy has been established through experts at the brown cancer center to understand further the role of cancer and the immune system to identify new therapeutic targets and develop innovative treatment strategies. Key service lines include multidisciplinary teams specializing in the treatment of: blood and bone marrow cancers, breast cancer, head and neck cancers, lung cancer, melanoma and other skin cancers, brain and spine cancers, gastrointestinal cancer, genitourinary cancer, gynecologic cancers, sarcoma, benign tumors and conditions.

Financial Efficiency

• Mission deployment rate: 77.5%; rating input score 78
• Program expense ratio: 88.2%; rating input score 88
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 93.3%; rating input score 93; 21st percentile among comparable filings
• Pay-setting controls: 4 of 6 controls in place; rating input score 67
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Limited
• Grant itemization coverage: 100%; rating input score 100; 53rd percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: No; rating input score 0

Accountability

• Independent voting board: 9.1%; rating input score 9; 8th percentile among comparable filings
• Governance controls: 8 of 9 controls in place; rating input score 89
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Fail
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 12.5%; rating input score 78; 78th percentile among comparable filings
• Total-asset coverage ratio: 1.13; rating input score 44; 44th percentile among comparable filings
• Liabilities to assets ratio: 0.42; rating input score 43; 43rd percentile among comparable filings
• Officer compensation ratio: 0.9%; rating input score 77; 77th percentile among comparable filings

Growth

• Program expense growth: 5.6% per year; rating input score 100; 45th percentile among comparable filings
• Revenue growth: 6.6% per year; rating input score 100; 57th percentile among comparable filings
• Asset growth: 8.6% per year; rating input score 100; 62nd percentile among comparable filings